Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zibo Baiji Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in Zibo, Shandong Province, China, focusing on the production of Active Pharmaceutical Ingredients (APIs) and high-end intermediates. The company is particularly recognized for its expertise in cardiovascular therapies, producing key small molecule drugs such as Atorvastatin Calcium, Clopidogrel Hydrogen Sulfate, and Rosuvastatin Calcium. Operating under strict international Good Manufacturing Practice (GMP) standards, Zibo Baiji provides high-quality chemical components to both domestic and global pharmaceutical markets. Its facilities are equipped with advanced cleanroom technology, reflecting its name 'Baiji,' which refers to Class 100 cleanliness standards. The company serves as a critical link in the generic drug supply chain, supporting the treatment of chronic conditions like hyperlipidemia and hypertension.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zibo Baiji Changsheng Pharmaceutical.